title: Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infection.
abstract: Hepatitis C virus subtype 3a is a highly prevalent and globally distributed strain that is often associated with infection via injection drug use. This subtype exhibits particular phenotypic characteristics. In spite of this, detailed genetic analysis of this subtype has rarely been performed. We performed full-length viral sequence analysis in 18 patients with chronic HCV subtype 3a infection and assessed genomic viral variability in comparison to other HCV subtypes. Two novel regions of intragenotypic hypervariability within the envelope protein E2, of HCV genotype 3a, were identified. We named these regions HVR495 and HVR575. They consisted of flanking conserved hydrophobic amino acids and central variable residues. A 5-amino-acid insertion found only in genotype 3a and a putative glycosylation site is contained within HVR575. Evolutionary analysis of E2 showed that positively selected sites within genotype 3a infection were largely restricted to HVR1, HVR495, and HVR575. Further analysis of clonal viral populations within single hosts showed that viral variation within HVR495 and HVR575 were subject to intrahost positive selecting forces. Longitudinal analysis of four patients with acute HCV subtype 3a infection sampled at multiple time points showed that positively selected mutations within HVR495 and HVR575 arose early during primary infection. HVR495 and HVR575 were not present in HCV subtypes 1a, 1b, 2a, or 6a. Some variability that was not subject to positive selection was present in subtype 4a HVR575. Further defining the functional significance of these regions may have important implications for genotype 3a E2 virus-receptor interactions and for vaccine studies that aim to induce cross-reactive anti-E2 antibodies.
authors.affiliation: Oxford NIHR Biomedical Research Centre and Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
authors.forename: Isla
authors.initials: I
authors.lastname: Humphreys
authors.forename: Vicki
authors.initials: V
authors.lastname: Fleming
authors.forename: Paolo
authors.initials: P
authors.lastname: Fabris
authors.forename: Joe
authors.initials: J
authors.lastname: Parker
authors.forename: Bodo
authors.initials: B
authors.lastname: Schulenberg
authors.forename: Anthony
authors.initials: A
authors.lastname: Brown
authors.forename: Charis
authors.initials: C
authors.lastname: Demetriou
authors.forename: Silvana
authors.initials: S
authors.lastname: Gaudieri
authors.forename: Katja
authors.initials: K
authors.lastname: Pfafferott
authors.forename: Michaela
authors.initials: M
authors.lastname: Lucas
authors.forename: Jane
authors.initials: J
authors.lastname: Collier
authors.forename: Kuan-Hsiang Gary
authors.initials: KH
authors.lastname: Huang
authors.forename: Oliver G
authors.initials: OG
authors.lastname: Pybus
authors.forename: Paul
authors.initials: P
authors.lastname: Klenerman
authors.forename: Eleanor
authors.initials: E
authors.lastname: Barnes
mesh_terms: D000595:Amino Acid Sequence; D014644:Genetic Variation / Q000235:genetics; D016679:Genome, Viral / Q000235:genetics; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics*; D006526:Hepatitis C / Q000821:virology*; D006801:Humans; D008969:Molecular Sequence Data; D010802:Phylogeny; D012641:Selection, Genetic